Epidemic Viral Pneumonia and Other Emerging Pathogens

Viruses cause a high percentage of community-acquired pneumonias. The advent of polymerase chain reaction and other molecular techniques has been associated with the detection of a higher prevalence of common respiratory viruses than previously suspected. Better diagnostics have shown new viral path...

Descripción completa

Detalles Bibliográficos
Autores principales: Radigan, Kathryn A., Wunderink, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130532/
https://www.ncbi.nlm.nih.gov/pubmed/21867815
http://dx.doi.org/10.1016/j.ccm.2011.05.010
_version_ 1783517031670218752
author Radigan, Kathryn A.
Wunderink, Richard G.
author_facet Radigan, Kathryn A.
Wunderink, Richard G.
author_sort Radigan, Kathryn A.
collection PubMed
description Viruses cause a high percentage of community-acquired pneumonias. The advent of polymerase chain reaction and other molecular techniques has been associated with the detection of a higher prevalence of common respiratory viruses than previously suspected. Better diagnostics have shown new viral pathogens regularly in epidemics, immunocompromised patients, and occasionally children. Despite better diagnostics, treatment for all but influenza is still very limited.
format Online
Article
Text
id pubmed-7130532
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71305322020-04-08 Epidemic Viral Pneumonia and Other Emerging Pathogens Radigan, Kathryn A. Wunderink, Richard G. Clin Chest Med Article Viruses cause a high percentage of community-acquired pneumonias. The advent of polymerase chain reaction and other molecular techniques has been associated with the detection of a higher prevalence of common respiratory viruses than previously suspected. Better diagnostics have shown new viral pathogens regularly in epidemics, immunocompromised patients, and occasionally children. Despite better diagnostics, treatment for all but influenza is still very limited. Elsevier Inc. 2011-09 2011-08-23 /pmc/articles/PMC7130532/ /pubmed/21867815 http://dx.doi.org/10.1016/j.ccm.2011.05.010 Text en Copyright © 2011 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Radigan, Kathryn A.
Wunderink, Richard G.
Epidemic Viral Pneumonia and Other Emerging Pathogens
title Epidemic Viral Pneumonia and Other Emerging Pathogens
title_full Epidemic Viral Pneumonia and Other Emerging Pathogens
title_fullStr Epidemic Viral Pneumonia and Other Emerging Pathogens
title_full_unstemmed Epidemic Viral Pneumonia and Other Emerging Pathogens
title_short Epidemic Viral Pneumonia and Other Emerging Pathogens
title_sort epidemic viral pneumonia and other emerging pathogens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130532/
https://www.ncbi.nlm.nih.gov/pubmed/21867815
http://dx.doi.org/10.1016/j.ccm.2011.05.010
work_keys_str_mv AT radigankathryna epidemicviralpneumoniaandotheremergingpathogens
AT wunderinkrichardg epidemicviralpneumoniaandotheremergingpathogens

Ejemplares similares